She commenced treatment with dapsone (DDS) four months ago, and the prognosis is good; the macules will re-pigment and there will be no further development of nerve damage. Had she been left untreated, the anesthesia which has already appeared in the left hand might have been followed by muscle wasting and claw-hand deformity similar to that on the other hand. Further, as these patients are immunologically unstable they are liable to progress to one of the determinate types of leprosy, and this patient, with her negative lepromin test, might later have become borderline or lepromatous. I The first is the diphenyl thiourea compound Ciba 1906. It is proving as effective as the sulphone group and has the advantage of being non-toxic. This is an important point, for the toxic effects of sulphone can be troublesome. It is, however, more expensive. Some patients have been treated with this compound for as long as three to four years, and that is a critical time for the possible development of resistance on the partoftheleprosybacilli. Dr.T.F.Davey in Nigeria has found resistance developing in a few instances at about the 40th month of treatment, but we are not yet in a position to say if this is likely to be a universal finding. Ciba 1906 can be prescribed on Form E.C.10.
The other big development in therapy is the production by I.C.I. of a derivative of ethyl mercaptan called ETIP. It has to be administered by inunction, and is still in the research stage. The most striking observation has been the rapid fall in the bacterial index of lepromatous cases within six to twelve weeks, and such a rapid action would suggest that its antibacterial action is entirely different from that of all other anti-leprosy drugs and is probably bactericidal. The chief disadvantage is that the leprosy bacilli appear to develop resistance after about three months, and therefore the drug can be used, on its own, for only a limited period of time. Work has yet to be done on combined treatment with other drugs. I feel sure that further research on derivatives of ethyl mercaptan will lead to still more sensational results. 
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Comment.-This patient is unusual in that the lesions are almost universal. It is of interest too that fungus has been found on apparently normal skin. That this finding results from a chance scattering of fungus on the surface is suggested by the negative PAS stain on a section from the area.
Treatment promises to be difficult; griseofulvin is to be given.
Dr. L. Forman: I have under treatment a similar case who presented as an exfoliative dermatitis. This developed after penicillin therapy for boils. Scrapings from the thigh showed fungus to be present. When the erythroderma subsided, the skin remained generally scaly. At any site, scrapings showed massive invasion of fungus, shown by Miss B. M. Partridge at the Institute of Dermatology to be Epidermophytonfloccosum. Prolonged treatment with local fungicides has been completely unsuccessful.
Dr. E. J. Moynahan: Several cases of generalized fungus infection have been described following cortisone treatment. I do not think this is particularly unusual. With regard to the distribution of different species of fungi on the skin I would say that Epidermophyton floccosum and the common trichophytes tend to avoid areas where sebaceous secretion is present. Nickerson has shown that certain fungi prefer to live on certain parts of the skin. This patient must be relatively unusual only in his reduced resistance to fungus infection. I have had a patient who had such a reduced resistance to Trichophyton rubrum that he only needed to go to a slightly warmer district such as the South of France for the lesions to spread rapidly all over the exposed skin of face and hands. There are some individuals who show this markedly reduced resistance to fungus infection and it seems that patients who have had a great deal of ACTH and cortisone may be rendered more liable to widespread fungus infection.
Dr. G. A. Beck: I agree that this is a beautiful case but I would think that it is not quite so rare as has been suggested. I have seen two or three such widespread cases. One, a very old man at St. John's Hospital, had an extensive rash on his body which, when we scraped it, grew T. rubrum. We also got T. rubrum from most of the other more usual sites. It cleared clinically fairly readily from his trunk but he still showed rubrum in scrapings from the apparently normal skin of his body.
Another is a war pensioner invalided out with universal eczema. When I saw him ten years later he still had widespread eczematous lesions on the lower limbs and lower part of his trunk. On scraping I found fungus, both in the clinically active eczematous areas, and in areas I regarded as normal allowing for the fact that he had had such extensive eczema for so long a time.
Dr. David Williams: I do not know whether I should say anything about griseofulvin. It is a very remarkable drug, although it does not seem to touch moniliasis, actinomycosis, blastomycosis or versicolor.
We have so far only treated 23 cases. Of 3 cases of ringworm of the scalp, 1 was quite readily and easily cured and the other 2 look as if they are going the same way; ordinary ringworm on the body disappears in two to three weeks. Infected nails appear to be growing out normally, but assessment of this is a long-term business. As to toxic effects, they have been so far negligible. I would expect this case to respond very well.
The President: We have had 2 patients develop a toxic erythema after this drug, one with sickness; 10 other cases had no ill-effects.
The following cases were also shown: Lichenoid Reticulosis of the Nape. 
